BRAF V600E mutation: a significant biomarker for prediction of disease in paediatric Langerhans cell histiocytosis

Basit Öğe Kaydı
dc.contributor.authorOzer, E.
dc.contributor.authorSevinc, A.
dc.contributor.authorInce, D.
dc.contributor.authorYuzuguldu, R.
dc.contributor.authorOlgun, N.
dc.date.accessioned2025-02-06T17:58:27Z
dc.date.available2025-02-06T17:58:27Z
dc.date.issued2019
dc.departmentAltınbaş Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.endpageS47en_US
dc.identifier.issn0945-6317
dc.identifier.issn1432-2307
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS47en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12939/5260
dc.identifier.volume475en_US
dc.identifier.wosWOS:000483546900148
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofVirchows Archiven_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250206
dc.titleBRAF V600E mutation: a significant biomarker for prediction of disease in paediatric Langerhans cell histiocytosisen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu